These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9116600)

  • 1. Chemotherapeutic treatments: a study of the interplay among drug resistance, toxicity and recuperation from side effects.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Mar; 59(2):205-32. PubMed ID: 9116600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1994; 11(1):45-59. PubMed ID: 8057040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug kinetics and drug resistance in optimal chemotherapy.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):191-209. PubMed ID: 7881194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal chemical control of populations developing drug resistance.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1992; 9(3):215-26. PubMed ID: 1295929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
    Boldrini JL; Costa MI
    IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical model of the development of drug resistance to cancer chemotherapy.
    Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some drug-resistant models for cancer chemotherapy. Part 1: Cycle-nonspecific drugs.
    Usher JR; Henderson D
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):99-126. PubMed ID: 8671582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
    Ledzewicz U; Schättler H
    Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of optimal control theory in cancer chemotherapy.
    Swan GW
    Math Biosci; 1990 Oct; 101(2):237-84. PubMed ID: 2134485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle.
    Murray JM
    Math Biosci; 1994 Oct; 123(2):183-213. PubMed ID: 7827419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some optimal control problems in cancer chemotherapy with a toxicity limit.
    Murray JM
    Math Biosci; 1990 Jun; 100(1):49-67. PubMed ID: 2134468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stochastic model of the acquisition of drug resistance during antineoplastic chemotherapy.
    Abundo M; Rossi C; Benassi M; Gentile FP; Mauro F
    Health Phys; 1989; 57 Suppl 1():349-54. PubMed ID: 2606692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An example of the effects of drug resistance on the optimal schedule for a single drug in cancer chemotherapy.
    Murray JM
    IMA J Math Appl Med Biol; 1995; 12(1):55-69. PubMed ID: 7594878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy.
    Jackson TL; Byrne HM
    Math Biosci; 2000 Mar; 164(1):17-38. PubMed ID: 10704636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency.
    Harnevo LE; Agur Z
    Cancer Chemother Pharmacol; 1992; 30(6):469-76. PubMed ID: 1394803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.
    Shah MA; Schwartz GK
    Clin Cancer Res; 2001 Aug; 7(8):2168-81. PubMed ID: 11489790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.